Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|September 27, 2015
Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patientsHaruka Shinke, Satohiro Masuda, Yousuke Togashi, et al.
Pharmacogenetics and Genomics|April 15, 2008
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patientsMasahide Fukudo, Ikuko Yano, Atsushi Yoshimura, et al.
Drug Metabolism and Pharmacokinetics|January 7, 2014
Evaluation of the potency of telaprevir and its metabolites as inhibitors of renal organic cation transporters, a potential mechanism for the elevation of serum creatinineTomohisa Nakada, Tomoko Kito, Katsuhisa Inoue, et al.
Pharmacogenetics and Genomics|December 18, 2009
Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patientsKana Toyama, Atsushi Yonezawa, Masahiro Tsuda, et al.
Pharmaceutical Research|February 27, 2004
Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseasesYuji Sakurai, Hideyuki Motohashi, Harumasa Ueo, et al.
Clinical Pharmacology and Therapeutics|October 4, 2006
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipientsMasahide Fukudo, Ikuko Yano, Satohiro Masuda, et al.
Biological & Pharmaceutical Bulletin|November 6, 2013
Influence of cytochrome P450 (CYP) 3A4*1G polymorphism on the pharmacokinetics of tacrolimus, probability of acute cellular rejection, and mRNA expression level of CYP3A5 rather than CYP3A4 in living-donor liver transplant patientsMiwa Uesugi, Mio Hosokawa, Haruka Shinke, et al.
Biochemical and Biophysical Research Communications|February 19, 2013
Sodium tauroursodeoxycholate prevents paraquat-induced cell death by suppressing endoplasmic reticulum stress responses in human lung epithelial A549 cellsTomohiro Omura, Masaru Asari, Joe Yamamoto, et al.
The Annals of Thoracic Surgery|July 28, 2016
Protective Effects of Imatinib on Ischemia/Reperfusion Injury in Rat LungSatona Tanaka, Toyofumi F Chen-Yoshikawa, Moto Kajiwara, et al.
Drug Metabolism and Pharmacokinetics|January 16, 2007
Temporal decline in sirolimus elimination immediately after pancreatic islet transplantationEriko Sato, Masahiro Shimomura, Satohiro Masuda, et al.
Pageof 16